PRF Technologies Ltd. PRFX 深 沪
等待开盘 04-02 09:30:00 美东时间
2.11
+0.085
+4.20%
华盛通- 最 高2.21
- 今 开2.03
- 成交量 1.32万股
- 最 低 2.02
- 昨 收 2.025
- 总市值 178.20万
- 52周最高 17.95
- 市盈率 静 --
- 换手率 1.56%
- 52周最低 1.7968
- 委 比 0.00%
- 总股本 84.46万
- 历史最高 9420.00
- 量 比 0.33
- 振 幅 9.38%
- 历史最低 2.02
- 每 手 1
- 风险率 2.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M
LayerBio's OcuRing™-K program and broader ocular platform strengthen PRF's healthcare growth strategyDeepSolar advances from acquisition to early commercial deployment
03-27 20:05
PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms
PRF Technologies Ltd. reported strategic advancements in healthcare and renewable energy in 2025, with the acquisition of LayerBio and DeepSolar marking its expansion into AI-driven solar analytics and sustained-release ocular therapies. The LayerBio acquisition advanced OcuRing™-K, a drop-less intraocular ring for post-cataract pain management, with preclinical and Phase I data supporting its safety and efficacy. PRF also expanded DeepSolar's co...
03-27 12:00
PRF Technologies Partnters With Blade Ranger Over Commercial Expansion Of Its DeepSolar Platform
PRF Technologies Ltd. (NASDAQ:PRFX) ("PRF" or the "Company") today announced a commercial collaboration agreement with Blade Ranger Ltd. (TASE: BLRN) designed to accelerate the commercial expansion of its DeepSolar
03-17 20:35
PRF Technologies Ltd. Announces Commercial Collaboration Agreement with Blade Ranger to Accelerate Large-Scale DeepSolar Commercial Engagements
PRF Technologies has teamed up with Blade Ranger to expand DeepSolar's reach in utility-scale solar markets. The partnership aims to secure multiple large-scale deployments, each targeting at least 150 MW. DeepSolar's AI platform enhances solar asset performance through improved forecasting, diagnostics, and real-time monitoring. This collaboration harnesses Blade Ranger's global renewable energy network to drive commercial growth amid a rapidly ...
03-17 12:30
PRF Technologies Strikes Agreement With Shikun & Binui Energy To Deploy DeepSolar At 71-MW Satu Mare Photovoltaic Site In Romania
PRF Technologies (Nasdaq: PRFX) ("PRF" or the "Company"), through its DeepSolar™ AI-driven solar analytics business unit, today announced the signing of a software-as-a-service (SaaS) agreement with Shikun &
02-11 21:35
PRF Technologies Wins Another European Utility-Scale Solar Deployment, Expanding DeepSolar’s Installed Commercial Base
Shikun & Binui Energy has selected DeepSolar's AI-driven solar analytics platform for its 71 MW Satu Mare solar project in Romania, marking a significant step in DeepSolar's expansion in European renewable-energy markets. The partnership aims to enhance operational efficiency and support data-driven decision-making through advanced analytics and performance monitoring. This deployment reflects Shikun & Binui Energy's growing presence in European ...
02-11 13:30
Why PainReform Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Shares of PainReform Ltd. (NASDAQ:PRFX) rose sharply in pre-market trading. The...
01-16 17:38
PainReform’s LayerBio’s Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical Studies
PainReform Ltd. and LayerBio, Inc. announced safety data supporting the continued development of OcuRing™-K, a drop-less, sustained-release ocular drug delivery platform for use in cataract surgery. Preclinical rabbit studies and a Phase I clinical study demonstrated a favorable safety profile, with no treatment-related safety concerns observed. The platform's sustained-release mechanism aims to minimize local irritation and systemic exposure. Pa...
01-12 14:00
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 14.1% to...
01-09 05:06
PainReform Commences Development Plan For OcuRing-K, LayerBio's Patented, Drop-Less, Intraoperatively Administered Sustained-Release Ocular Therapy
PainReform Ltd. (NASDAQ:PRFX) today announced, through its pharmaceutical division, the commencement of its development plan for OcuRing™-K, LayerBio's patented, drop-less, intraoperatively administered
2025-12-02 22:20
